Chinese Biotechs Join COVID-19 Treatment Race With Repurposed Cancer Drugs

 
• By Dexter Jie Yan

Chinese bioventures leap into the COVID cure fray as two little-known companies kick off clinical studies of androgen receptor antagonists in Brazil and the US.

China COVID antiAndrogen drugs
Second-Only Chinese Biotech Joins The Hunt For COVID-19 Cure With a Me-Too of Xtandi • Source: Alamy

More from China

More from Focus On Asia